DePuy Spine has launched the EXPEDIUM Neuromuscular System to address spinal and pelvic deformity in patients with neuromuscular scoliosis, according to a DePuy news release.
Spinal Tech
Several medical and orthopedic device company stocks recovered after suffering significant losses at the end of last week, perhaps due to a Center for Medicare and Medicaid Services announcement that it would conduct checks before authorizing select treatment in the…
A new report from Millennium Research Group suggests that orthopedic surgeons are content with orthopedic device companies and their products, while other specialists, such as cardiologists, express more discontent, according to a MRG news release.
Several spine surgeons recently gave presentations about sacroiliac joint pain at the EuroSpine and North American Spine Society annual meetings, according to an SI-BONE news release.
Plainsboro, N.J.-based orthopedic device company Integra LifeSciences recently opened its first Asian business office in Shanghai, China, as part of an ongoing expansion into the medical device market, according to an Integra news release.
Advertisement
Here are 10 orthopedic and spine surgeons who have been appointed to medical and scientific advisory boards of device companies since last December.
An orthopedic surgeon with Miller Orthopaedic Affiliates in Council Bluffs, Iowa, is currently participating in an FDA trial of the Oxford Cementless Partial Knee Replacement from Biomet, according to a report from The Daily Nonpareil.
Ortho-tag has partnered with the University of Pittsburgh to use the Transcutaneous Near Field Communication technology in "smart" orthopedic implants, according to an NFC News report.
Mazor Robotics recently reported $1.6 million in third quarter sales, which is a slight increase over the $1.5 million it reported for the same period last year, according to a Mazor news release.
Michel Orsinger, CEO of Synthes, recently received $52 million as a result of Johnson & Johnson's acquisition of the company, if the deal closes sometime over the next two years, according to a Philadelphia Inquirer report.